7.7 million Americans have diabetic retinopathy right now. By 2050, the CDC projects that number will hit 14.6 million as the diabetes epidemic continues its slow march forward. Most of those people don’t know it yet — the disease does its damage in silence, before symptoms appear. By the time vision blurs, the window for cheap, effective treatment is often already closing.
The cost of catching diabetic retinopathy early is $50–$150 per year. The cost of treating advanced disease can run well past $20,000.
Stage-by-Stage Treatment Costs
How much you spend depends almost entirely on how advanced your disease is when it’s found.
| Stage | Treatment | Cost Per Session | Annual Cost |
|---|---|---|---|
| Mild-moderate NPDR | Observation + annual exam | $150–$300/visit | $150–$600 |
| Severe NPDR/early PDR | Anti-VEGF injections | $50–$2,100/injection | $600–$25,000 |
| PDR with neovascularization | Pan-retinal photocoagulation (PRP) laser | $800–$2,000/session | $1,600–$4,000 |
| PDR with vitreous hemorrhage | Vitrectomy surgery | $15,000–$25,000 | One-time (or per eye) |
| Diabetic macular edema (DME) | Anti-VEGF injections | $50–$2,100/injection | $600–$25,000 |
NPDR = non-proliferative diabetic retinopathy; PDR = proliferative diabetic retinopathy. The shift from NPDR to PDR marks the point where new blood vessels start growing — abnormal, fragile ones that leak and bleed. That’s when treatment urgency accelerates.
Anti-VEGF Injections for Diabetic Macular Edema
Diabetic macular edema (DME) is the most common cause of vision loss in people with diabetes. It’s swelling of the macula — the sharp-focus center of your retina — caused by leaking diabetic blood vessels. Anti-VEGF injections are the first-line treatment, and they work: in the DRCR Retina Network Protocol T trial, all three major anti-VEGF drugs produced significant vision gains compared to sham treatment.
Avastin (bevacizumab) at $50–$80/injection is used off-label. Many retinal specialists start there and step up to Eylea or Vabysmo for patients who don’t respond. (Full drug-by-drug pricing is in our macular degeneration treatment cost guide.)
The typical protocol runs monthly for 3–6 months to load the eye, then stretches to every 4–12 weeks for maintenance. Early DME caught before central vision is affected has the best prognosis — catching it in the loading-dose phase is very different from chasing it after months of untreated progression.
The American Diabetes Association recommends annual dilated retinal exams for everyone with type 1 diabetes (starting 5 years after diagnosis) and everyone with type 2 diabetes (starting at diagnosis). A dilated exam costs $50–$150. Retinal photography adds $30–$100.
Medicare covers these at 80%. Early-stage diabetic retinopathy runs $150–$600/year to monitor. Skip the exam, let disease advance undetected, and you’re potentially looking at $20,000+ to treat what could have been found for $100.
Laser Treatment Costs
Pan-retinal photocoagulation (PRP) laser treats proliferative diabetic retinopathy by destroying peripheral retinal tissue — tissue that’s driving abnormal blood vessel growth by demanding oxygen the diseased microvasculature can’t supply. It sounds drastic. It works, and it’s been working since the 1970s. Today it’s often combined with anti-VEGF injections for faster response.
Two sessions per eye is typical. At $800–$2,000/session, the full treatment runs $1,600–$4,000 per eye. Medicare Part B covers PRP at 80% as a medically necessary procedure.
Focal laser for DME — targeting specific leaking vessels rather than the whole retinal periphery — costs $600–$1,500 per session. It’s been largely displaced by anti-VEGF injections for most patients, but it still has a role in specific clinical situations.
Vitrectomy: When Surgery Is the Only Option
If diabetic retinopathy produces vitreous hemorrhage (bleeding into the gel-filled chamber of the eye) or tractional retinal detachment from scar tissue pulling the retina away from the wall of the eye, vitrectomy surgery becomes necessary. This is major intraocular surgery — performed in a surgery center or hospital — removing the clouded vitreous and addressing the underlying retinal damage.
Total cost including surgeon, facility, and anesthesia: $15,000–$25,000 per eye. Medicare pays 80% after the Part B deductible. With Medicare only, you’re looking at $3,000–$5,000 out of pocket per eye before any supplemental coverage kicks in.
The DCCT trial — one of the landmark diabetes studies — showed that intensive blood glucose control reduces the risk of developing diabetic retinopathy by 76% and slows progression by 54%. Your endocrinologist and your ophthalmologist are fighting the same disease from different directions. A1C improvements you make now affect your retinas years from now. Both appointments matter.
Insurance and Financial Assistance
Medicare Part B covers medically necessary diabetic eye care: the annual dilated exam, OCT imaging, laser procedures, injections, and surgery. Medicaid covers diabetic eye care in most states. For uninsured or underinsured patients, pharmaceutical manufacturer assistance programs exist for Eylea, Vabysmo, and Lucentis — worth asking the retinal specialist’s office about.
Bottom Line
Monitoring early-stage diabetic retinopathy runs $150–$600/year. DME or proliferative DR requiring injections costs $600–$25,000/year before insurance. PRP laser runs $1,600–$4,000/eye. Vitrectomy is $15,000–$25,000/eye. Medicare covers most treatment at 80%. The real leverage is the annual dilated eye exam — finding disease early, when it’s a $150 monitoring situation rather than a $15,000 surgical one, is the single best financial and clinical decision a person with diabetes can make.